With all of those huge wins in the rearview mirror, Tame Impala has extended his ‘Deadbeat Tour’ and invited special guests Djo and Dominic Fike along for the ride on select dates. The new batch of ...

Tame Impala brings new life to its hit song “Dracula” with a remix featuring BLACKPINK member Jennie, the Julian Klincewicz-directed lyric video for which can be seen below. The original version, from ...

BLACKPINK’s Jennie and Tame Impala’s new collab is out! On February 6, Jennie’s remix of Tame Impala’s hit track “Dracula” was officially released across music platforms, along with a new lyrics video ...

Feb 3 (Reuters) - South Africa's Impala Platinum (IMPJ.J), opens new tab on Tuesday said it expects its half-year profit to increase by as much as 392%, mainly driven by higher metal prices. The ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Most car shoppers gravitate toward SUVs and crossovers these days, leaving traditional sedans to quietly fade from the spotlight. That’s a bit of a shame for anyone who still appreciates the ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...